Coronavirus | China joins COVAX vaccine alliance

The alliance is designed so that richer countries agree to buy into potential vaccines and help finance access for poorer ones.

A model of a coronavirus is displayed next to boxes for COVID-19 vaccines at an exhibit by Chinese pharmaceutical firm Sinopharm at the China International Fair for Trade in Services (CIFTIS) in Beijing, Saturday, Sept. 5, 2020. China said Friday, Oct. 9, 2020, that it is joining the COVID-19 vaccine alliance known as COVAX.

China, which has four coronavirus vaccine candidates in stage 3 clinical trials, said on Friday that it is joining the coronavirus vaccine alliance known as COVAX.

The country signed an agreement with GAVI, the co-leader of the alliance, on Thursday, China’s Foreign Ministry said in a statement. Initially, China did not agree to join the alliance, missing the global deadline to join in September.

“We are taking this concrete step to ensure equitable distribution of vaccines, especially to developing countries, and hope more capable countries will also join and support COVAX,” Foreign Ministry spokeswoman Hua Chunying said in a statement.

It is not yet clear the exact terms of the agreement and how China will contribute. The country’s leader Xi Jinping previously said that China would make the vaccine a global public good.

The alliance is designed so that richer countries agree to buy into potential vaccines and help finance access for poorer ones. The Trump administration in the US had declined to join the alliance.